首页 | 本学科首页   官方微博 | 高级检索  
检索        

PTPN22基因多态性与自身免疫甲状腺病的相关性
引用本文:于志云,张进安,买尔哈巴,王宇,肖婉侠,全瑛,董宝宁.PTPN22基因多态性与自身免疫甲状腺病的相关性[J].细胞与分子免疫学杂志,2008,24(8):804-807.
作者姓名:于志云  张进安  买尔哈巴  王宇  肖婉侠  全瑛  董宝宁
作者单位:1. 西安交通大学医学院第一附属医院内分泌科,陕西,西安,710061;西安市卫生学校,陕西,西安,710054
2. 西安交通大学医学院第一附属医院内分泌科,陕西,西安,710061
3. 新疆医科大学第一附属医院内分泌科,新疆,乌鲁木齐,830054
摘    要:目的:检测PTPN22基因的单核苷酸多态性(SNP)及其与中国人自身免疫甲状腺病(AITD)的相关性, 并研究CTLA- 4基因SNP与PTPN22 SNP的相互关系.方法:采用PCR-RFLP技术分析231例AITD患者, 其中Graves'病(GD)149例, 桥本甲状腺炎(HT)82例和131例健康对照者PTPN22基因 1858 C>T及CTLA- 4基因49A>G位点的基因型.采用SASP-PCR技术分析PTPN22基因启动子-1123G>C的基因型.结果:(1)PTPN22基因的 1858C>T位点不存在多态性;(2)PTPN22基因-1123G>C SNP的等位基因和基因型分布频率在GD组与正常对照组间的差异有统计学意义(P值分别为0.040和0.013, OR值分别为1.44和2.33);(3) CTLA- 4基因 49A>G位点的等位基因和基因型分布频率在AITD组与正常组间有明显差异;(4)与携带PTPN22的G等位基因及CTLA- 4的AA基因型者相比, 携带PTPN22CC基因型与CTLA- 4 AG或GG基因型者发生GD的OR值=3.31(95%CI: 2.69-8.89).结论:PTPN22基因启动子-1123G>C SNP与GD的发生相关, 其CC基因型与CTLA- 4基因的G 等位基因对GD的发生起协同作用.

关 键 词:蛋白酪氨酸磷酸酶非受体型22基因  自身免疫性甲状腺病  单核苷酸多态性  基因多态性  自身免疫  甲状腺病  相关性  AITD  gene  protein  tyrosine  phosphatase  polymorphism  协同作用  基因对  发生  正常组  统计学意义  差异  正常对照组  分布频率  等位基因  存在  结果  基因启动子

Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD
YU Zhi-yun,ZHANG Jin-an,Maier-haba,WANG Yu,XIAO Wan-xia,QUAN Ying,DONG Bao-ning.Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD[J].Journal of Cellular and Molecular Immunology,2008,24(8):804-807.
Authors:YU Zhi-yun  ZHANG Jin-an  Maier-haba  WANG Yu  XIAO Wan-xia  QUAN Ying  DONG Bao-ning
Institution:Department of Endocrinology, First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an 710061, China.
Abstract:AIM: To evaluate the association of PTPN22 gene polymorphism with autoimmune thyroid disease (AITD) in Chinese people and to analyze the relationship between SNP of CTLA-4 gene and SNP of PTPN22 gene. METHODS: 149 patients with Graves' disease (GD) and 82 patients with Hashimoto's thyroiditis (HT) as well as 131 healthy people as controls were investigated. PTPN22 gene polymorphism +1858 C>T and CTLA-4 gene polymorphism 49A>G were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). PTPN22 gene polymorphism -1123G>C at promoter was genotyped by single allele-specific primer polymerase chain reaction (SASP-PCR). RESULTS: (1) +1858C>T for PTPN22gene was not polymorphic enough in patients and controls. (2) Statistic differences in alleles and genotype frequency of -1123G>C were observed between GD patients and controlsèP=0.040, 0.013; OR=1.44, 2.33, respectivelyé. (3) Differences in alleles and genotype frequency of 49A>G for CTLA-4 gene were observed in patients and controls. (4) Individuals with PTPN22 CC genotype and CTILA-4 G alleles had an increased risk of developing GD (OR=3.31, 95%CI: 2.69-8.89) compared with those with PTPN22 G alleles and CTLA-4 AA genotype. CONCLUSION: -1123 G>C SNP of PTPN22 gene is associated with GD. There is coordination between PTPN22 CC genotype and CTLA-4 G alleles in the development of GD.
Keywords:
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号